Reviva pharmaceuticals announces letter to shareholders

Cupertino, calif., jan. 04, 2023 (globe newswire) -- reviva pharmaceuticals holdings, inc. (nasdaq: rvph) (“reviva” or the “company”), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (cns), cardiovascular, metabolic, and inflammatory diseases, is pleased to announce a letter to shareholders from founder, president, and ceo, laxminarayan bhat, ph.d.
RVPH Ratings Summary
RVPH Quant Ranking